European Journal of Pharmaceutical Sciences Pharmaceutical Science

A mechanistic pharmacokinetic–patient-derived organoid (PK–PDO) framework for comparing oxaliplatin HIPEC regimens in peritoneal metastases of colorectal cancer

Pouya Namakshenas, Roxan F.C.P.A. Helderman, Wim Ceelen, H. Petra Kok, Johannes Crezee
Elsevier · 2027-01-01 · DOI 10.1016/j.ejps.2026.107702

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →